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The mitochondrial uniporter (MCU) is an ion channel
that mediates Ca2+ uptake into the matrix to regulate
metabolism, cell death, and cytoplasmic Ca2+
signaling. Matrix Ca2+ concentration is similar to
that in cytoplasm, despite an enormous driving force
for entry, but the mechanisms that prevent mito-
chondrial Ca2+ overload are unclear. Here, we show
that MCU channel activity is governed by matrix
Ca2+ concentration through EMRE. Deletion or
charge neutralization of its matrix-localized acidic
C terminus abolishes matrix Ca2+ inhibition of MCU
Ca2+ currents, resulting in MCU channel activation,
enhanced mitochondrial Ca2+ uptake, and constitu-
tively elevated matrix Ca2+ concentration. EMRE-
dependent regulation of MCU channel activity
requires intermembrane space-localized MICU1,
MICU2, and cytoplasmic Ca2+. Thus, mitochondria
are protected from Ca2+ depletion and Ca2+ overload
by a unique molecular complex that involves Ca2+
sensors on both sides of the inner mitochondrial
membrane, coupled through EMRE.
INTRODUCTION
The mitochondrial calcium uniporter is a Ca2+-selective ion
channel localized in the inner mitochondrial membrane (IMM)
(Gunter et al., 1994; Kirichok et al., 2004) that mediates Ca2+ up-
take into themitochondrial matrix from the cytoplasm to regulate
metabolism, cell death, and cytoplasmic Ca2+ signaling. Under
normal resting conditions, the matrix-free Ca2+ concentration
is similar to that in the cytoplasm (Luka´cs andKapus, 1987; Nich-
olls, 2009), despite an enormous180 mV driving force for Ca2+
entry generated by proton pumping by the respiratory chain,
suggesting that the Ca2+ uniporter possesses mechanisms to
inactivate it under resting conditions to prevent mitochondrial
Ca2+ overload. However, the nature of such mechanisms is un-Cclear. The mitochondrial Ca2+ uniporter is a complex of proteins,
including the Ca2+ selective pore-forming subunit mitochondrial
uniporter (MCU) and accessory proteins, including MICU1,
MICU2, MCUR1, and EMRE (De Stefani and Rizzuto, 2014; Fos-
kett and Philipson, 2015; Kamer et al., 2014). Previously, it was
suggested that either MICU1 or MICU2 provided a so-called
gatekeeping function that reduces MCU-mediated Ca2+ uptake
in situ below a threshold value of 1–2 mM external free Ca2+
(the low cytoplasmic [Ca2+] regime) to prevent mitochondrial
Ca2+ loading under basal conditions (Csorda´s et al., 2013; Malli-
lankaraman et al., 2012; Patron et al., 2014), most likely by
reducing MCU single-channel open probability. However, it is
unclear whetherMICU proteins exert their effects from thematrix
or intermembrane space (IMS) or if Ca2+ binding to their pairs of
EF hands is required (Foskett and Madesh, 2014). Furthermore,
their regulation of MCU-mediated Ca2+ uptake has not been
examined by electrophysiological studies of the uniporter chan-
nel directly in its nativemembrane environment, so themolecular
details of channel regulation by MICU1 and MICU2 remain un-
known. The importance of understanding this regulatory mecha-
nism is underscored by patients with loss of function mutations
inMICU1, who lack inhibition ofmitochondrial Ca2+ uptake under
basal conditions and exhibit proximal myopathy, learning diffi-
culties, and a progressive extrapyramidal movement disorder
(Logan et al., 2014).
RESULTS
We recorded uniporter Ca2+ currents (IMiCa) using patch clamp
electrophysiology of mitoplasts (Fieni et al., 2012; Kirichok
et al., 2004; Vais et al., 2015) isolated from human embryonic kid-
ney (HEK) cells. In the whole-mitoplast recording configuration
with the pipette solution lacking Ca2+, ruthenium red (RuR,
200 nM)-sensitive Ca2+ currents were observed (Figure 1A)
with densities and properties similar to those previously reported
for IMiCa withmatrix [Ca
2+] buffered either at zero or >10 mM (Fieni
et al., 2012; Kirichok et al., 2004). Similar currents were nearly
abolished in cells with MCU knocked down (Figure 1B), confirm-
ing their identity as uniporter currents. Unexpectedly, IMiCa was
markedly reduced when matrix [Ca2+] was raised from 0 into aell Reports 14, 403–410, January 26, 2016 ª2016 The Authors 403
Figure 1. MCU Channel Activity Is Modulated by a Mechanism
Dependent upon Matrix [Ca2+]
(A) MCU current density in various bath [Ca2+] (indicated in inset) with 0 Ca2+
(1.5 mMEGTA) in the pipette solution, in response to voltage ramps from160
to 60 mV. Inhibition by ruthenium red (RuR, 200 nM) in 1 mM bath Ca2+ is also
shown.
(B) MCU current density measured from MCU-KD cells.
(C) Similar to (A), recorded with pipette solution containing 400 nM free Ca2+.
(D) Response ofMCUCa2+current density at Vm =160mV, with 1mMCa2+ in
the bath, as function of free [Ca2+] in pipette (matrix) solution. Data are fitted
with a biphasic Hill equation (continuous line).range from 30 to400 nM (Figure 1C), resulting in a biphasicma-
trix [Ca2+] dependence with apparent inhibition constant of 60 ±
30 nM and Hill coefficient of 1.0 ± 0.2, and apparent recovery
constant of 730 ± 15 nM and Hill coefficient of 3.1 ± 1.6, with
peak inhibition of MCU currents by 75% at 400 nM (Fig-
ure 1D). Of note, resting matrix [Ca2+] is 100–300 nM (Boyman
et al., 2014; Brandenburger et al., 1996; Ivannikov and Macleod,
2013; Luka´cs and Kapus, 1987; Nicholls, 2009; Palmer et al.,
2006), suggesting that this inhibition of MCU activity may be
related to the previously reported inhibition of MCU activity in
the low Ca2+ regime attributed to MICU1 and MICU2.
Using a proteinase sensitivity assay (Sato and Mihara, 2010),
we determined that MICU1 and MICU2 are localized outside of404 Cell Reports 14, 403–410, January 26, 2016 ª2016 The Authorsthe matrix, in the IMS (Figure S1A), in agreement with other re-
ports (Csorda´s et al., 2013; Kamer and Mootha, 2014; Lam
et al., 2015; Petrungaro et al., 2015; Sancak et al., 2013). This
suggested that matrix [Ca2+] regulation of IMiCa is mediated by
MCU itself or by another matrix-localized Ca2+ binding protein.
Plasma membrane Ca2+ channels also have Ca2+-dependent
channel inactivation, usually mediated by an associated protein
(Christel and Lee, 2012). EMRE is a single-pass 10 kD IMM pro-
tein that binds to MCU and is required for uniporter activity (San-
cak et al., 2013), although its function is unknown. By protease
sensitivity biochemistry, we determined that the C terminus of
EMRE faces into the mitochondrial matrix (Figures 2A and
S1B). The C terminus contains a conserved acidic motif that is
homologous to the Ca2+ binding ‘‘Ca2+ bowl’’ and ‘‘Ca2+ clasp’’
in Ca2+-activated large conductance (BK) K+ and bestrophin Cl
channels, respectively (Figure S1C). We speculated that it simi-
larly bound Ca2+ in EMRE. Deletion of the EMRE C terminus or
charge neutralization of its seven terminal acidic residues (Fig-
ure S1C) was without effect on MICU1 or MICU2 localization
(Figure S1D), EMRE topology (Figures S1D and S1E), expression
of MCU, MICU1 or MICU2 (Figure S2C), or ability of EMRE to
interact with MCU (Figure S3), but it abolished matrix [Ca2+]
regulation of uniporter Ca2+ currents (Figures 2B–2F). Loss of
matrix [Ca2+] inhibition of MCU channel activity in mutant
EMRE-expressing cells resulted in constitutively elevated matrix
[Ca2+] (Figures 2G–2L and S4).
To determine the relationship between these observations and
previously reported regulation of MCU activity by MICU1 and
MICU2, we examined MCU activity in intact mitochondria by
simultaneous measurements of mitochondrial Ca2+ uptake and
mitochondrial membrane potential in permeabilized HEK293
cells, as previously described (Mallilankaraman et al., 2012).
Addition of digitonin to permeabilize the plasma membrane
and thapsigargin to inhibit SERCA activity slowly raised bath
[Ca2+] due to leak of Ca2+ from the ER. Addition of CGP37157
(CGP) to inhibit the IMM Na+/Ca2+ exchanger and reveal the
rate of unidirectional mitochondrial Ca2+ uptake reversed that
trend for all cells with functional MCU (Figures 2M and 2N). In
contrast, the slow rise in bath [Ca2+] was unaffected by CGP
addition in EMRE-KO cells (Figure 2N), reflecting the absence
of mitochondrial Ca2+ uptake, as expected since EMRE KO ab-
rogates MCU activity in HEK293 cells (Sancak et al., 2013). In
response to addition of a 10 mM Ca2+ bolus, bath [Ca2+] was
rapidly reduced by MCU-mediated Ca2+ uptake in WT cells,
whereas it remained high with no reduction in EMRE-KO cells
(Figure 2N), confirming that EMRE is critical for MCU Ca2+ chan-
nel function. Control experiments showed complete abrogation
of IMiCa in EMRE-KO cells (n = 6; data not shown). MCU-medi-
ated Ca2+ uptake in response to addition of a 10 mM Ca2+ bolus
was restored in EMRE-rescue cells (Figure 2N) and in cells
rescued with carboxyl-terminus mutant EMRE (Figure 2M).
Unidirectional Ca2+ uptake through MCU observed after CGP
addition (Figures 2M and 2N) reduced bath [Ca2+] for WT cells
to a significantly higher level than that for mutant EMRE cells,
indicating that inhibition of MCU activity in the low cytoplasmic
[Ca2+] regime that terminated Ca2+ uptake in WT cells was lost
in cells expressing mutant EMRE. Even in the absence of Na+/
Ca2+ exchanger activity in WT cells, no decrease in bath [Ca2+]
Figure 2. The C terminus of EMRE Confers Matrix [Ca2+] Sensitivity to MCU Activity
(A) The C terminus of EMRE resides in the matrix. EMRE rescue (V5-tagged EMRE overexpressed in EMRE-KO cells) was probed for its amino (a-EMRE) and
carboxyl (a-V5) termini. C terminus is protected from protease similarly to matrix-localized proteins.
(B–D) MCU current densities in various bath [Ca2+], recorded from mitoplasts from EMRE KO cells expressing WT EMRE (B), EMRE-DC (C), or EMRE-QN6 (D),
with pipette solution containing 400 nM free Ca2+. Color schemes are as in Figure 1.
(E) Summary of experiments shown in (B)–(D). Means and SEMs. WT (Figure 1D) and EMRE-rescue data are included for comparison.
(F) Response of MCU Ca2+current density at Vm = 160 mV, with 1 mM Ca2+ in the bath, as function of free [Ca2+] in pipette (matrix) solution for indicated cells,
showing loss of matrix [Ca2+] regulation in mitoplasts expressing EMRE-QN6. WT data are fitted with a biphasic Hill equation (continuous line).
(G–K) Basal Rhod-2 fluorescence in cells stably expressing EMRE constructs.
(L) Rhod-2 fluorescence quantification (fluorescence a.u. [f.a.u.]; mean ± SEM, n = 3).
(legend continued on next page)
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was detected after the addition of a 0.5 mM Ca2+ bolus (Fig-
ure 2N), whereas bath [Ca2+] was restored to the pre-Ca2+ addi-
tion level after the addition of 0.5 mM Ca2+ to C terminus mutant
EMRE cells (Figure 2N), suggesting also that normal inhibition of
MCU activity in the low cytoplasmic [Ca2+] regime was impaired
by EMRE C terminus charge neutralization or deletion. These re-
sults indicate that EMRE is a Ca2+ sensor that mediates [Ca2+]
regulation of uniporter activity.
It was originally reported that MICU1 conferred inhibition of
MCU-mediated mitochondrial Ca2+ influx in the low cytoplasmic
[Ca2+] regime (Mallilankaraman et al., 2012). It was subsequently
suggested that MICU2 instead mediates this inhibition of MCU
activity (Patron et al., 2014). Measurements of mitochondrial
Ca2+ uptake in permeabilized cells confirmed that knockout
(KO) of either MICU1 or MICU2 abrogated normal inhibition of
MCU activity in the low cytoplasmic [Ca2+] regime (Figure 3A), re-
sulting in constitutive matrix Ca2+ loading (Figures 3B–3D and
S4). To explore the relationship between the EMRE-dependent
matrix [Ca2+] regulation of IMiCa and apparent inhibitory functions
of MICU proteins, we recorded IMiCa in cells with either MICU
protein knocked down. Remarkably, knockdown or KO of either
MICU1 or MICU2 (Figure S2A and S2B) abolished matrix [Ca2+]
regulation of IMiCa (Figures 3E and 3F). IMiCa regulation (Figures
3E and 3F) and constitutive mitochondrial Ca2+ loading (Figures
3B and 3C) were rescued by expression of the WT proteins (Fig-
ures 3F and 3H–3L). These results indicate that matrix [Ca2+]
regulation of IMiCa is part of the so-called gatekeeping mecha-
nism underlying previously reported inhibition of MCU activity
in the low cytoplasmic [Ca2+] regime.
It was suggested thatMICU1- (Csorda´s et al., 2013) orMICU2-
mediated (Patron et al., 2014) inhibition of MCU activity does not
require Ca2+ binding to their EF hands. To explore the role of
cytoplasmic Ca2+ in EMRE regulation of MCU activity, we
removed Ca2+ from the bath and recorded MCU activity by
measuring Na+ currents (Figures 4A–4C) (Fieni et al., 2012; Kiri-
chok et al., 2004). Normal matrix [Ca2+] (400 nM) inhibition of
MCU activity was eliminated in the absence of bath Ca2+ (Figures
4A–4C), suggesting that Ca2+ binding in the IMS, perhaps to
MICU1 and/or MICU2 or MCU itself, is required for EMRE-
dependent matrix [Ca2+] regulation of IMiCa. It has been sug-
gested that MICU2 suppresses MCU activity (Patron et al.,
2014). However, comparable Na+ currents were recorded in
MICU2 KO cells (Figure 4C).
DISCUSSION
Our results suggest a model employing Ca2+ sensors on both
sides of the IMM in which the activity of the MCU is tuned to pro-
vide optimal Ca2+ influx into the mitochondrial matrix under
resting conditions. EMRE is a sensor of matrix [Ca2+] that gov-
erns the inhibition of uniporter activity under normal conditions,(M) Gatekeeping measured by mitochondrial Ca2+ uptake (average traces; n = 3)
evidenced by MCU-mediated Ca2+ uptake following inhibition of the Na+/Ca2+ ex
WT cells and their ability to rapidly take up Ca2+ following addition of 500 nM Ca
(N) Similar to (M), demonstrating lack of MCU activity in EMRE KO cells (no Ca2+ u
gatekeeping and Ca2+ uptake in WT and EMRE-rescue cells.
See also Figures S1–S4.
406 Cell Reports 14, 403–410, January 26, 2016 ª2016 The Authorsacting to prevent mitochondrial Ca2+ loading under basal condi-
tions. This function requires conserved acidic residues in thema-
trix-localized carboxyl tail of EMRE as well as MICU1 andMICU2
and Ca2+ on the opposite side of the IMM (Figures 4D and S4B).
Of note, EMRE mediates the interaction of MICU proteins with
MCU (Sancak et al., 2013), suggesting a possible mechanism
for EMRE and MICU proteins to have coupled functions.
EMRE-dependent matrix [Ca2+] regulation of IMiCa may also
play a role in preventing mitochondrial Ca2+ depletion when
cytoplasmic [Ca2+] becomes low ormitochondrial Ca2+ extrusion
exceeds influx (Figures 4D and S4B). Under such conditions,
Ca2+ may dissociate from EMRE and possibly MICU proteins,
relieving inhibition of MCU and enabling uniporter activity to in-
crease to preserve matrix [Ca2+] to support critical mitochondrial
functions (Ca´rdenas et al., 2010). Thus, mitochondria are pro-
tected both from Ca2+ depletion under low-Ca2+ conditions
and from Ca2+ loading under normal resting conditions by a
unique molecular complex that involves Ca2+ sensors on both
sides of the IMM, governed by EMRE. Our results suggest a
model in which agonist-generated cytoplasmic Ca2+ signals
raise matrix [Ca2+] due to the non-zero open probability of
MCU under basal conditions to a level (>1 mM; Figure 1D) that re-
lieves EMRE-mediated matrix [Ca2+] inhibition of uniporter activ-
ity (Figures 1D, 4D, and S4B), enabling agonist-activated cyto-
plasmic Ca2+ signals to be conveyed to the matrix to stimulate
respiration. The mechanism of matrix [Ca2+]-mediated relief
from inhibition is highly cooperative (apparent Hill coefficient
3, Figure 1D) and may therefore account for observed cooper-
ative Ca2+ activation of the uniporter (Bragadin et al., 1979;
Gunter and Pfeiffer, 1990; Zoccarato and Nicholls, 1982) without
the need to invoke amplification byCa2+ binding toMICU1 (Csor-
da´s et al., 2013; Perocchi et al., 2010). Importantly, the nature of
the mechanism(s) involved in matrix [Ca2+] activation of the uni-
porter remains to be determined (Figures 4D and S4B).
EXPERIMENTAL PROCEDURES
Cell Lines and Constructs
WT HEK293T, MICU1-KO, MICU2-KO, and EMRE-KO cell lines were grown in
DMEM supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin,
and 100 mg/ml streptomycin at 37C and 5% CO2. All KO cell lines were gifts
from Dr. Vamsi Mootha. MICU1 knockdown (KD) cells were generated by len-
tiviral transduction of shRNAs targeting MICU1; transduced cells were
selected and maintained in complete DMEM supplemented with puromycin
(2 mg/ml), as described (Mallilankaraman et al., 2012). Full-length MICU1,
MICU2, and EMRE cDNAs were purchased from Origene Technologies.
EMRE-DC-V5 and EMRE-QN6-V5 constructs were generated by a PCR-
based cloning strategy. All constructs were sequence verified and stably
transfected into either KD or KO backgrounds.
Uniporter Electrophysiology
Mitoplast electrophysiology was performed as described (Fieni et al., 2012;
Kirichok et al., 2004; Vais et al., 2015). For IMiCa measurements, patchin permeabilized cells is abolished in cells expressing the EMRE-QN6 mutant,
changer with CGP that reduces baseline bath [Ca2+] to much lower levels than
2+ bolus. Tg, thapsigargin, 2 mM; digitonin, 40 mg/ml. See text for details.
ptake following CGP addition or after addition of 10 mMCa2+ bolus) and normal
Figure 3. MICU1 and MICU2 Are Required for Matrix [Ca2+] Regulation of MCU
(A) Average traces (n = 3) of bath [Ca2+] showing inhibition of gatekeeping in MICU1-KO and MICU2-KO cells, as evidenced by MCU-mediated Ca2+ uptake that
reduces baseline bath [Ca2+] to much lower levels than WT cells and ability of KO cells to rapidly take up Ca2+ following addition of 500 nM Ca2+ bolus.
(B and C) Basal Rhod-2 fluorescence in MICU1-KO (B) and MICU2-KO (C) cells.
(D) Quantification of Rhod-2 fluorescence (mean ± SEM, n = 3).
(E and F) Representative MCU currents in various bath [Ca2+] from mitoplasts from MICU1-KD (E) or MICU1-rescue (F) cells, with pipette solution containing
400 nM free Ca2+. Color scheme is as in Figure 1.
(G and H) Representative MCU currents in various bath [Ca2+] recorded from MICU2-KO (G) or MICU2 rescue (H) mitoplasts, with pipette solution containing
400 nM free Ca2+. Color scheme is as in Figure 1.
(I) Summary of MCU current densities over range of matrix [Ca2+] in mitoplasts from WT and MICU1 and MICU2 KD/KO and rescue cells.
(J and K) Basal Rhod-2 fluorescence in MICU1 (J) and MICU2 (K) rescue cells.
(L) Quantification of Rhod-2 fluorescence (mean ± SEM, n = 3).
See also Figure S2 and S4.pipettes with tip diameters significantly less than 1 mm had resistances of 20–
60 MU when filled with (in mM) TMA-OH, 130 mM; HEPES, 100; glutathione,
10; MgCl2, 2; EGTA, 1.5 (pH = 7.0) with D-gluconic acid; osmolarity 330–350
mOsm/kg. EGTA was also used to buffer different amounts of CaCl2, for
[Ca2+]free %600 nM. However, EGTA was replaced by 1.5 mM of dibromo-
Bapta (for 600 nM < [Ca2+]free % 4 mM), HEDTA (for 4 mM % [Ca
2+] free %
30 mM), or NTA (for [Ca2+] free = 100 mM). In all pipette solutions, [Ca
2+] free
(< 100 mM) was confirmed by Ca2+-indicator dye fluorimetry. For Na+ currentCmeasurements, pipettes were filled with (in mM) Na-gluconate, 110; HEPES,
40; NaCl, 2; EGTA, 1; EDTA, 5; CaCl2, see above (pH = 7.0) with NaOH; os-
molarity 330–350 mOsm/kg. Mitoplasts were initially bathed in (in mM): KCl,
150; HEPES, 10; EGTA, 1 (pH = 7.2); osmolarity 300 mOsm/Kg (‘‘KCl-DVF’’
solution). Voltage pulses of 350–500 mV amplitude and 15–50 ms duration,
delivered by the PClamp-10 (Molecular Devices) program, were used to
obtain the ‘‘whole-mitoplast’’ configuration. Access resistance (30–90 MU)
and mitoplast capacitance Cm (0.2–1 pF) were determined using theell Reports 14, 403–410, January 26, 2016 ª2016 The Authors 407
Figure 4. Matrix [Ca2+] Regulation of MCU
Requires Cytoplasmic Ca2+
(A) Representative MCU-mediated Na+ currents
(red trace) recorded in absence of bath Ca2+ with
no free Ca2+ in pipette. Addition of 160 nM free
Ca2+ to bath completely blocked the Na+ current
(orange trace).
(B) Same as in (A), recorded with pipette solution
containing 400 nM free Ca2+.
(C) Summary of MCU Na+ current densities in
different cell types with pipette solutions with or
without 400 nM free Ca2+.
(D) Model for MCU regulation, with Ca2+ sensors on
both sides of the IMM: EMRE and an unknown
protein (box associated with MCU in the cartoon)
sense matrix [Ca2+] ([Ca2+]m); MICU1 and/or
MICU2, through their paired EF hands (red dots),
represent IMS cytoplasmic Ca2+ ([Ca2+]cyt) sen-
sor(s). Under normal resting conditions (middle
conformation), channel open probability is strongly
reduced (gatekeeping) when sensors on both sides
of the IMM are liganded with Ca2+ (red dots with
question marks signify Ca2+ binding sites possibly
liganded). Channel inhibition is effective in the
range of [Ca2+]m = 50–800 nM, with maximal inhi-
bition at [Ca2+]m 400 nM (from IMiCa biphasic
matrix [Ca2+] dependence with apparent inhibition
constant of 60 nM and apparent recovery constant
of 730 nM; Figure 1D) with peak inhibition of
MCU currents by 75% at 400 nM (25% open
probability indicated by dashed line in middle
conformation) and [Ca2+]cyt between resting levels and 2 mM (from permeabilized cell measurements here and in Mallilankaraman et al., 2012). Physiological
relief of MCU channel inhibition is achieved by agonist-induced elevated [Ca2+]cyt that drives Ca
2+ into the matrix, raising [Ca2+]m to levels (>800 nM) that result in
highly cooperative activation (Hill coefficient > 3) of mitochondrial Ca2+ influx by unknownmechanisms (right conformation, with the unknown matrix reactivation
mechanism[s] depicted as a Ca2+ binding protein with multiple Ca2+ binding sites, and MICU proteins with EF hands fully liganded). MCU channel inhibition can
also be relieved by very low [Ca2+]m (left conformation) as a result of Ca
2+ unbinding from EMRE, independent of the Ca2+ binding states of MICU proteins (see
also Figure S4B).membrane test protocol of the PClamp-10 software. Because the volume of
a mitoplast is more than three orders of magnitude smaller than that of a
cell, we assumed that matrix [Ca2+]free rapidly equilibrated with pipette
[Ca2+]free. After the whole-mitoplast configuration was obtained, the KCl-
DVF bath solution was exchanged with HEPES-EGTA (in mM): HEPES, 150;
EGTA, 1.5 (pH = 7.0) with Tris-base for baseline (control) measurements, fol-
lowed by HEPES (no EGTA) solutions with 0.1, 0.3, 1 mM CaCl2, successively.
Finally, a HEPES-based solution with 1 mM CaCl2 and 200 nM ruthenium red
(RuR) was perfused into the bath to record the final baseline ( = IRuR) after
block of MCU Ca2+ currents. For MCU Na+ current measurements, the
HEPES-EGTA control solution was instead exchanged with (in mM): Na-glu-
conate, 110; HEPES, 40; EGTA, 1; EDTA, 5 (pH = 7.0), followed by the same
solution supplemented with 4 mM CaCl2 ([Ca
2+]freez180 nM, estimated with
the MaxChelator software) to block the Na+ currents. Osmolarities of all
bath solutions were 297–305 mOsm/Kg, adjusted with sucrose. The voltage
protocol, delivered by the PClamp-10 software with a DigiData-1550 interface
(Molecular Devices), consisted of stepping from Vm = 0 mV to 160 mV for
20 ms, followed by ramping to 80 mV (rate of 279 mV/s), dwelling at 80 mV
for 20 ms and return to 0 mV. Currents were recorded using an Axopatch
200-B amplifier. Data were acquired at room temperature with a sampling
rate of 50 kHz and anti-aliasing filtered at 1 kHz. Data analysis was performed
with the PClamp-10 software. For quantitative comparisons, current den-
sities, defined as follows,
IMCU=Cm = ðICa  IRuRÞ=Cm;
with ICa and IRuR measured at Vm = 160 mV in the presence of 1 mM Ca2+
in the bath, were used. WT data corresponding to various concentrations of408 Cell Reports 14, 403–410, January 26, 2016 ª2016 The Authorsfree Ca2+ in the pipette solution ( = [Caf]) were fitted with the biphasic Hill
equation:
IMCU=Cm = ðIMCU=CmÞmax
 
1 ½Caf 
Hinh
½Caf Hinh +KHinhinh
3
KHrecrec
½Caf Hrec +KHrecrec
!
;
where Hinh and Hrec are the Hill coefficients for inhibition and recovery from
inhibition, respectively, while Kinh and Krec are the correspondent midpoint
pipette [Caf]. Least-square fitting was done with IGOR Pro software
(WaveMetrics).Analysis of Uniporter Gatekeeping by Simultaneous Measurement
of Mitochondrial Ca2+ Uptake and Mitochondrial Membrane
Potential in Permeabilized Cells
Simultaneous measurement of mitochondrial Ca2+ uptake and mitochondrial
membrane potential (DJm) in permeabilized HEK293 cells was performed as
described (Mallilankaraman et al., 2012), with experimental data converted
to and represented as bath [Ca2+]. In brief, cells were trypsinized, counted,
and washed in a Ca2+-free buffer, centrifuged, and transferred to an intracel-
lular-like medium (in mM: 120 KCl, 10 NaCl, 1 KH2PO4, 20 HEPES-Tris, 2 suc-
cinate [pH 7.2], protease inhibitors, 2 mM thapsigargin, 40 mg/ml digitonin) in a
spectrofluorometer. FuraFF (0.5 mM) was added at 0 s and JC-1 (800 nM) at
20 s to measure extra-[Ca2+]m and DJm at 37
C. Fluorescence wasmonitored
in a temperature-controlled (37C) multi-wavelength-excitation dual wave-
length-emission spectrofluorometer (Delta RAM, Photon Technology Interna-
tional) using 490-nm excitation/535-nm emission for the monomer, 570-nm
excitation/595-nm emission for the J-aggregate of JC1, and 340/380 nm for
FuraFF. In this study, the size of the Ca2+ boluses added to stimulate subse-
quent mitochondrial Ca2+ uptake did not change DJm.
Qualitative Measurement of Basal [Ca2+]m
Qualitative measurement of basal [Ca2+]m was determined as we previously
described (Mallilankaraman et al., 2012). Briefly, cells (5 3 105/well) grown
on 0.2% gelatin-coated coverslips in six-well dishes were loaded with 2 mM
rhod-2 AM for 50 min in extracellular medium containing 2 mM Ca2+. Cover-
slips were mounted in an open perfusion microincubator (PDMI-2; Harvard
Apparatus) and imaged at 37C. All confocal images, obtained at 561 nm exci-
tation using a 633 oil objective, were rapid 100 ms ‘‘snapshots’’ to avoid
phototoxicity. All imaging used identical gain and exposure settings that
enabled threshold detection of basal Rhod-2 fluorescence in control WT cells.
Accordingly, the contribution of low-level diffuse background cytoplasmic
Rhod-2 was essentially eliminated. Addition of the mitochondrial uncoupler
CCCP (2–10 mM) was added to ensure that punctate fluorescence emanated
from mitochondria (Figure S4). Images were analyzed using ImageJ software
(NIH) as described (Mallilankaraman et al., 2012).
Topology Analysis
Topology analyses of MICU1, MICU2, and EMRE were performed by protein-
ase K protection assay as described (Sato et al., 1998). Mitochondria were iso-
lated by differential centrifugation as described (Sato et al., 1998). Immediately
after isolation, the mitochondrial pellet was resuspended in MIM buffer
(280 mM sucrose with 10 mM HEPES [pH 7.2]). Mitochondria (40 mg per con-
dition) were placed in MIM buffer containing varying concentrations of digi-
tonin (0%–2%) and constant concentration of Proteinase-K (100 mg/ml) for
15 min at room temperature. Samples without proteinase-K or with 1% Triton
X-100 served as controls. Proteinase-K was inactivated by addition of 10 mM
PMSF, and samples were subjected to western or dot blotting.
Western Blotting
Cells kept on ice were lysed with 13RIPA lysis buffer (Millipore) supplemented
with protease inhibitors (Complete, Roche). Membranes were blocked in 5%
fat-free milk 1 hr at room temperature, incubated O/N at 4C with primary
antibody, and then for 2 hr at RT with a secondary antibody conjugated to
horseradish peroxidase (HRP). Chemiluminescence detection used ECL-
plus reagent (Pierce). To ensure equal protein loading across gels, membranes
were stripped (Restore western blot stripping buffer; Pierce) and re-probed
with a loading control antibody. For dot blots, protein samples were spotted
onto nitrocellulose membranes using a slot blot apparatus, and immunoblot-
ting was performed as described above. Antibodies for MICU1 (ab102830,
Abcam; 1:200) and (HPA037480, Sigma-Aldrich; 1:300); MICU2 (ab101465,
Abcam 1:500) and (HPA045511; Sigma-Aldrich); MCU (HPA016480,
Sigma-Aldrich; 1:500); EMRE (sc-86337; Santa Cruz Biotechnology) and
(HPA032117, Sigma-Aldrich; 1:200); Tom20 (ab56783; Abcam); Tim23
(611223; BD Biosciences); Tim44 (ab168649; Abcam); Oxa1L (66128-1-Ig;
proteintech); HSP60 (ab13532; Abcam); anti-V5 (R960-25, Life technologies;
1:1000); anti-actin (A2228, Sigma-Aldrich 1:2000); anti-FLAG (TA 50011,
Origene 1:500); anti-mouse IgG-HRP (7076S, Cell Signaling; 1:1000); and
anti-rabbit IgG-HRP (7074S, Cell Signaling; 1:1000) were used in the study.
All experiments were done in triplicate.
Co-immunoprecipitation
HEK293 cells (EMRE KO, EMRE KO + QN6 EMRE-V5, and EMRE KO + WT
EMRE-V5) were grown to confluency in 150 mm plates. Cells were washed
twice with PBS and lysed with 1-ml cold lysis buffer (50 mM HEPES-KOH
[pH 7.4], 150 mM NaCl, 0.2% n-dodecyl-b-D-maltoside, 0.5 mM EGTA,
0.3 mM CaCl2, one complete protease inhibitor tablet [Roche] per 30 ml lysis
buffer). Cells were lysed at 4C for 30 min and centrifuged at 16,000 3 g.
Cleared lysates were diluted to normalize for protein concentration. Appro-
priate volumes of lysates were added, corrected for expression levels based
on western blotting and densitometric analysis. Anti-V5 Agarose (30 ml ;
Sigma-Aldrich #A 7345) was added to diluted lysates and rocked 16 hr at
4C. Beads were washed with 1ml PBS 33 and boiled in 90 ml 23 SDS sample
buffer; 20 ml of each immunoprecipitate and 30 mg of total cell lysates were
loaded on Tris-Glycine gels for western blotting. To maintain a constant rangeC[Ca2+] in lysis and wash buffers, CaCl2 and EGTA were added to buffers ac-
cording to http://maxchelator.stanford.edu. In addition, [Ca2+] in each prepa-
ration was measured with Fura-2. Solutions contained 150–450 nM free Ca2+.
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